Cécile L Berends

Characterization of Triptolide-Induced Hepatotoxicity by Imaging and Transcriptomics in a Novel Zebrafish Model

D. Webb, J. Dear, J. Mullins, 2017, Toxicological sciences : an official journal of the Society of Toxicology.

Phase 1 clinical trial of losmapimod in facioscapulohumeral dystrophy: Safety, tolerability, pharmacokinetics, and target engagement

L. Ronco, B. V. van Engelen, D. Cadavid, 2021, British journal of clinical pharmacology.

MicroRNA‐122 can be measured in capillary blood which facilitates point‐of‐care testing for drug‐induced liver injury

J. Dear, M. Kersaudy-Kerhoas, A. D. B. Vliegenthart, 2017, British journal of clinical pharmacology.

First‐in‐human trial to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of STR‐324, a dual enkephalinase inhibitor for pain management

G. Groeneveld, I. Kamerling, E. Klaassen, 2021, British journal of clinical pharmacology.

Validation of a pharmacological model for mitochondrial dysfunction in healthy subjects using simvastatin: A randomized placebo‐controlled proof‐of‐pharmacology study

W. Teeuwisse, A. Webb, J. Beenakker, 2017, European journal of pharmacology.

Viral clearance, pharmacokinetics and tolerability of ensovibep in patients with mild to moderate COVID‐19: A phase 2a, open‐label, single‐dose escalation study

M. Vissers, G. Groeneveld, J. Burggraaf, 2022, British journal of clinical pharmacology.

A novel sustained‐release cysteamine bitartrate formulation for the treatment of cystinosis: Pharmacokinetics and safety in healthy male volunteers

M. Moerland, J. Burggraaf, I. Kamerling, 2021, Pharmacology research & perspectives.